Zenas BioPharma's CEO Purchased 60,000 Company Shares. Here's a Deeper Look at the Transaction.
This clinical-stage biotech focused on immunology therapies reported a notable insider buy amid a year of strong stock performance.
Overview
Leon O. Molder Jr., Chief Executive Officer of Zenas BioPharma (NASDAQ:ZBIO), reported the open-market purchase of 60,000 shares at a weighted average price of $16.88 per share, according to the SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($16.88). Post-transaction value based on May 18, 2026 closing price.
Details
* 1-year performance calculated using May 18, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.